View all results
No results
News
Events
The industry
Industry overview
Industrial biotech
Swiss Biotech Report
Success stories
Company directory
Jobs
Talent platform
Networking platforms
Newsletter
Association
Mission & services
Members
Academy
Insight Events
Partners
Team
Media
Add listing
Log in
or
Register
0
Add listing
PQR530 (panPI3K/mTOR)
Verified listing
PQR530 (panPI3K/mTOR)
Verified listing
Product
prev
next
Leave a review
Bookmark
Share
Report
prev
next
Indicaton
Lymphomas / Solid Tumors
Therapeutic indications
CNS
Genetic disorder
Neuromuscular
Oncology
Type of product
Small molecule
Table
Phase
Discovery
You may also be interested in
Proclarix
Proclarix® is CE marked, intended for in vitro diagnostic use and indicated for prostate cancer diagnosis in patients with normal digital rectal exam (DRE), enlarged prostate volume and elevated levels of PSA at 2-10 ng/ml.
Featured
Marketed
Dimiracetam
Management of acute and chronic symptoms of chemotherapy-induced sensory peripheral neuropathy.
Featured
Phase II started
Small molecule therapeutic that aims to treat Alzheimer’s patients
Alzheimer’s disease
Featured
Discovery
Cart
×
View all results
No results
X
WhatsApp
LinkedIn
Mail
Copy link
Share via...
Bluesky
This site uses cookies:
Find out more.
Accept